Typhoid Antibody Testing Market Share

  • Report ID: 4164
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Typhoid Antibody Testing Market Share

APAC Market Forecast

The typhoid antibody testing market in Asia Pacific is projected to hold the highest market share of 41% by the end of 2036. This is backed by the increase in typhoid cases in developing countries such as India, China, Bangladesh, Nepal, Vietnam, and Laos. These countries report more than 75% of typhoid cases around the world.

Moreover, various government-led initiatives aiming at managing the number of cases and spreading awareness and preventive measures are some factors that are expected to enhance the market growth in this region. For instance, in 2019, more than 450,000 typhoid cases have been found in Bangladesh, of which about 7,400 cases resulted in death.

European Market Statistics

The typhoid antibody testing market in Europe is poised to hold a significant market share of 29% by the end of 2025, owing to a highly developed healthcare infrastructure that includes fabulous levels of hygiene and sanitization facilities. They have proper personal hygiene products and public hygiene facilities, along with proper drinking water and food, owing to which a very low number of typhoid cases could be seen in this region. As per World Health Organization, Europe accounts for less than 500 cases of typhoid every year.

Research Nester
Typhoid Antibody Testing Market Size
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4164
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of typhoid antibody testing is estimated at USD 1.15 Billion.

The typhoid antibody testing market size was valued at USD 1.08 Billion in 2023 and is expected to cross USD 2.75 Billion by the end of 2036, registering more than 7.5% CAGR during the forecast period i.e., between 2024-2036. Typhoid is on the rise in developing countries and increased competition among top competitors to produce fast and cost-effective diagnostic kits to diagnose typhoid cases is anticipated to boost the market growth.

Asia Pacific is set to hold the highest revenue share of 41% by 2036, driven by increase in typhoid cases in the region.

IDL Biotech AB, LINEAR CHEMICALS, S.L.U, Medical Innovation Ventures Sdn Bhd, Thermo Fisher Scientific, Nectar Lifesciences Ltd., DIALAB GmbH., BIOSYSTEMS S.A., Siemens Healthcare GmbH, NanoEnTek, CerTest Biotec S.L.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying